Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma.
Saved in:
| Title: | Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma. |
|---|---|
| Authors: | Chou WH; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA., Lawrence L; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA., Neham E; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Akilesh S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Moran AE; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Corless CL; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA., Langmesser L; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA., Cengiz B; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Eckenstein K; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Liu JJ; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Isharwal S; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Amling CL; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Strother MC; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Chakiryan NH; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Urology, Portland VA Medical Center, Portland, OR 97239, USA., Thomas GV; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA. |
| Source: | Cancers [Cancers (Basel)] 2026 Jan 20; Vol. 18 (2). Date of Electronic Publication: 2026 Jan 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers18020312 |
